Literature DB >> 11960650

Chromosome 7q21-22 and multiple sclerosis: evidence for a genetic susceptibility effect in vicinity to the protachykinin-1 gene.

Koen Vandenbroeck1, Pierre Fiten, Shirley Heggarty, An Goris, Eleonora Cocco, Stanley A Hawkins, Colin A Graham, Maria G Marrosu, Ghislain Opdenakker.   

Abstract

Chromosome 7q21-22 and, in particular, the region surrounding D7S554 emerged from the recent American genome screen in multiple sclerosis (MS) as the most promising region genome-wide for harboring a disease susceptibility gene. We tested association between D7S554 and MS in 217 Sardinian trio MS families by the transmission disequilibrium test (TDT), and in a Northern Irish case-control study comprising 542 individuals. In both populations, we found evidence for significant allelic association (P(c)=0.04 and P(c)=0.0002, respectively). In a second stage, we analysed five microsatellite markers in a 4 megabase interval on chromosome 7q21-22 in the same set of Sardinian families. Parental transmission of a single allele of one of these markers, i.e. D7S3126, was significantly distorted (P(c)=0.008). D7S554 and D7S3126 are located at distances of, respectively, 40 and 81 kb 5' from the startcodon of the protachykinin-1 gene (TAC1), and occur in strong linkage disequilibrium (P<10(-7)). Our study indicates that the previous finding of linkage with D7S554 refers possibly to the presence of an MS susceptibility effect in vicinity to TAC1. In addition, a second independent association was uncovered between a microsatellite polymorphism in the plasminogen activator inhibitor-1 gene, i.e. D7S477, and MS. Overall, the analysis presented here may contribute to the increasingly refined genomic map of MS and underscores the requirement for a further high-resolution screening of chromosome 7q21-22.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11960650     DOI: 10.1016/s0165-5728(02)00023-1

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  7 in total

1.  A susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprinting.

Authors:  Ari Karason; Johann E Gudjonsson; Ruchi Upmanyu; Arna A Antonsdottir; Valdimar B Hauksson; E Hjaltey Runasdottir; Hjortur H Jonsson; Daniel F Gudbjartsson; Michael L Frigge; Augustine Kong; Kari Stefansson; Helgi Valdimarsson; Jeffrey R Gulcher
Journal:  Am J Hum Genet       Date:  2002-12-09       Impact factor: 11.025

2.  Substance P and Antagonists of the Neurokinin-1 Receptor in Neuroinflammation Associated with Infectious and Neurodegenerative Diseases of the Central Nervous System.

Authors:  Alejandra N Martinez; Mario T Philipp
Journal:  J Neurol Neuromedicine       Date:  2016

Review 3.  Integrating genomic and clinical medicine: searching for susceptibility genes in complex lung diseases.

Authors:  Ankit A Desai; Pirro Hysi; Joe G N Garcia
Journal:  Transl Res       Date:  2007-12-18       Impact factor: 7.012

4.  Interleukin-1beta upregulates functional expression of neurokinin-1 receptor (NK-1R) via NF-kappaB in astrocytes.

Authors:  Chang-Jiang Guo; Steven D Douglas; Zhiyong Gao; Bryan A Wolf; Judith Grinspan; Jian-Ping Lai; Eric Riedel; Wen-Zhe Ho
Journal:  Glia       Date:  2004-11-15       Impact factor: 7.452

5.  Making genomics functional: deciphering the genetics of acute lung injury.

Authors:  Ryan Kamp; Xiaoguang Sun; Joe G N Garcia
Journal:  Proc Am Thorac Soc       Date:  2008-04-15

6.  Reciprocal Regulation of Substance P and IL-12/IL-23 and the Associated Cytokines, IFNγ/IL-17: A Perspective on the Relevance of This Interaction to Multiple Sclerosis.

Authors:  Janek Vilisaar; Kiyokazu Kawabe; Manjit Braitch; Jehan Aram; Yasemin Furtun; Angela J Fahey; Mark Chopra; Radu Tanasescu; Patrick J Tighe; Bruno Gran; Charalabos Pothoulakis; Cris S Constantinescu
Journal:  J Neuroimmune Pharmacol       Date:  2015-02-18       Impact factor: 4.147

Review 7.  The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders.

Authors:  M Brittany Johnson; Ada D Young; Ian Marriott
Journal:  Front Cell Neurosci       Date:  2017-01-04       Impact factor: 5.505

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.